Vaccination

Question 1

Birth Vaccination

Answer 1

Hepatitis B

Question 2

2 months vaccination

Answer 2

Hepatitis B
DTap
Rota
Hib
IPV (Polio)
PCV (pneumococcal)

Question 3

4 months vaccination

Answer 3

Hepatitis B
DTap
Rota
Hib
IPV (Polio)
PCV (pneumococcal)

Question 4

6 months vaccination

Answer 4

Hepatitis B
DTap
Rota
Hib
IPV (Polio)
PCV (pneumococcal)
Influenza (1st shot)

Question 5

12 months vaccination

Answer 5

MMR
Hepatitis A (6 months between doses)
DtaP
Hib
PCV
Varicella
“MAD HPV”

Question 6

4-6 years old vaccination

Answer 6

Varicella
DTaP
IPV
Influenza
MMR
“Very DIM”

Question 7

11-12 years old vaccination

Answer 7

Meningitis
Influenza
TdaP
HPV
“MITH”

Question 8

16-18 Years old vaccination

Answer 8

Meningitis booster & annual flu shot

Question 9

Hepatitis B Vaccine: Mother is HBsAg-positive

Answer 9

Birth dose (monovalent HepB vaccine only): administer HepB vaccine and hepatitis B immune globulin (HBIG) (in separate limbs) within 12 hours of birth, regardless of birth weight.

Birth weight <2000 grams: administer 3 additional doses of HepB vaccine beginning at age 1 month (total of 4 doses)

Test for HBsAg and anti-HBs at age 9–12 months. If HepB series is delayed, test 1–2 months after final dose. Do not test before age 9 months.

Question 10

Hepatitis B: Mother is HBsAg-unknown

Answer 10

Birth dose (monovalent HepB vaccine only):
Birth weight ≥2,000 grams: administer HepB vaccine within 12 hours of birth. Determine mother’s HBsAg status as soon as possible. If mother is determined to be HBsAg-positive, administer HBIG as soon as possible (in separate limb), but no later than 7 days of age.
Birth weight <2,000 grams: administer HepB vaccine and HBIG (in separate limbs) within 12 hours of birth. Administer 3 additional doses of HepB vaccine beginning at age 1 month (total of 4 doses)

Question 11

Hepatitis B Contraindication

Answer 11

Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine component3 including yeast

Question 12

Rotavirus Vaccination Catch-up vaccination

Answer 12

Do not start the series on or after age 15 weeks, 0 days

The maximum age for the final dose is 8 months, 0 days

Question 13

Rota Vaccination Contraindication

Answer 13

History of intussusception

Question 14

DTaP contraindication

Answer 14

Encephalopathy (e.g., coma, decreased level of consciousness, prolonged seizures) not attributable to another identifiable cause within 7 days of administration of previous dose of DTP or DTaP

Question 14

Tdap special situations

Answer 14

For clean and minor wounds, administer Tdap or Td if more than 10 years since last dose of tetanus-toxoid-containing vaccine; for all other wounds, administer Tdap or Td if more than 5 years since last dose of tetanus-toxoid-containing vaccine. Tdap is preferred for persons age 11 years or older who have not previously received Tdap or whose Tdap history is unknown.

Question 15

Tdap contraindication

Answer 15

Encephalopathy (e.g., coma, decreased level of consciousness, prolonged seizures) not attributable to another identifiable cause within 7 days of administration of previous dose of DTP, DTaP, or Tdap

Question 16

HPV Special situations

Answer 16

Immunocompromising conditions, including HIV infection: 3-dose series, even for those who initiate vaccination at age 9 through 14 years.

History of sexual abuse or assault: Start at age 9 years

Question 17

HPV Contraindication/not recommended

Answer 17

Pregnancy: HPV vaccination not recommended

if allergic to yeast (Gardasil)

Question 18

Hib catch up vaccination

Answer 18

1 dose administered at age 15 months or older: No further doses needed
Unvaccinated at age 15–59 months: Administer 1 dose.
Previously unvaccinated children age 60 months or older who are not considered high risk: Do not require catch-up vaccination

Question 19

Hib Contraindication

Answer 19

For Hiberix, ActHib, and PedvaxHIB only: History of severe allergic reaction to dry natural latex
Age <6 weeks

Question 20

PCV/PPSV23 special situation

Answer 20

When both PCV and PPSV23 are indicated, administer PCV first. PCV and PPSV23 should not be administered during the same visit

Sickle cell disease and other hemoglobinopathies; anatomic or functional asplenia; congenital or acquired immunodeficiency; HIV infection; chronic renal failure; nephrotic syndrome; malignant neoplasms, leukemias, lymphomas, Hodgkin disease, and other diseases associated with treatment with immunosuppressive drugs or radiation therapy; solid organ transplantation; multiple myeloma:
Age 2–5 years
Any incomplete* series with:
3 PCV doses: 1 dose PCV (at least 8 weeks after any prior PCV dose)
Less than 3 PCV doses: 2 doses PCV (8 weeks after the most recent dose and administered 8 weeks apart)
No history of PPSV23: 1 dose PPSV23 (at least 8 weeks after completing all recommended PCV doses) and a dose 2 of PPSV23 5 years later

Age 6–18 years
No history of either PCV or PPSV23: 1 dose PCV, 2 doses PPSV23 (dose 1 of PPSV23 administered 8 weeks after PCV and dose 2 of PPSV23 administered at least 5 years after dose 1 of PPSV23)
Any PCV but no PPSV23: 2 doses PPSV23 (dose 1 of PPSV23 administered 8 weeks after the most recent dose of PCV and dose 2 of PPSV23 administered at least 5 years after dose 1 of PPSV23)
PPSV23 but no PCV: 1 dose PCV at least 8 weeks after the most recent PPSV23 dose and a dose 2 of PPSV23 administered 5 years after dose 1 of PPSV23 and at least 8 weeks after a dose of PCV

Question 20

PCV contraindication

Answer 20

Severe allergic reaction (e.g., anaphylaxis) to any diphtheria-toxoid– containing vaccine or its component3